Hyundai Bioscience

T cell attacking Covid-19
#Anti-virals #Covid-19 #Hyundai Bioscience #Long Covid #University of California San Diego

Hyundai Bioscience investigates antiviral for long Covid in US trial

Hyundai Bioscience USA and the University of California San Diego (UCSD) have agreed to conduct a clinical trial to evaluate the efficacy of Xafty, a niclosamide-based antiviral, in treating long Covid. “This is an outstanding opportunity for UCSD  and Hyundai Bioscience to partner together to tackle… Read More

#News